SOMAmer technology to diagnose coronavirus infection: veterinary and zoonotic implications.
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: 2601029
Grant search
Key facts
Disease
N/A
Start & end year
20212025Known Financial Commitments (USD)
$0Funder
UK Research and Innovation (UKRI)Principal Investigator
N/A
Research Location
United KingdomLead Research Institution
UNIVERSITY OF OXFORDResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
Innovation
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This project aims to research the development of a multiplex diagnostic Lateral Flow Device (LFD) to identify and differentiate coronavirus infections, aid more effective decision-making on interventions, and identify the occurrence and co-occurrence of infections from a single sample. This DPhil project will utilise aptamer technology, which is analogous to antibodies in function. Aptamers are oligonucleotides, small single-stranded DNA or RNA structures capable of specific binding to a selected protein target and therefore are ideal for diagnostic and therapeutic applications. Aptamers in addition offer further utility in terms of speed, cost, and flexibility in developing diagnostic tools compared to traditional monoclonal antibody applications. Furthermore, advanced highly modified DNA aptamers, specifically utilising SOMAmer technology (Slow off-rate modified aptamers) offer greater stability for long term storage.